Cyclic GMP Production by ANP, BNP, and NO during Worsening and Improvement of Chronic Heart Failure
Open Access
- 1 January 2003
- journal article
- Published by International Heart Journal (Japanese Heart Journal) in Japanese Heart Journal
- Vol. 44 (5) , 713-724
- https://doi.org/10.1536/jhj.44.713
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 22 references indexed in Scilit:
- Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart FailureCirculation, 1997
- Marked expression of plasma brain natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathyJournal of the American College of Cardiology, 1996
- Increased plasma levels of B-type natriuretic peptide in patients with unstable anginaAmerican Heart Journal, 1996
- Plasma Brain Natriuretic Peptide as an Indicator of Left Ventricular Systolic Function and Long-term Survival After Acute Myocardial InfarctionCirculation, 1996
- Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.Circulation, 1994
- Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.Circulation, 1993
- Prognostic importance of atrial natriuretic peptide in patients with chronic heart failureJournal of the American College of Cardiology, 1989
- A membrane form of guanylate cyclase is an atrial natriuretic peptide receptorNature, 1989
- In vivo evidence that cGMP is the second messenger for atrial natriuretic factor.Proceedings of the National Academy of Sciences, 1986
- RAPID INCREASE IN PLASMA AND URINARY CYCLIC GMP AFTER BOLUS INJECTION OF ATRIAL NATRIURETIC FACTOR IN MANJournal of Clinical Endocrinology & Metabolism, 1985